[LXRX] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
08-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -12.52%
YoY- -113.37%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 162 39 23 6,634 294,448 6,856 26,942 -57.34%
PBT -50,525 -23,387 -23,122 82,603 220,072 -27,512 -30,722 8.64%
Tax 2,854 292 -90 4,118 -6,014 783 2,034 5.80%
NP -50,525 -23,679 -23,122 82,603 226,086 -27,512 -30,722 8.64%
Tax Rate - - - -4.99% 2.73% - - -
Total Cost 50,687 23,718 23,145 -75,969 68,362 34,368 57,664 -2.12%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -31,188.27 -60,715.38 -100,530.43 1,245.15 76.78 -401.28 -114.03 154.66%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.21 -0.14 -0.16 0.77 2.13 -0.26 -0.29 -5.23%
EPS Diluted -0.21 -0.14 -0.16 0.71 1.95 -0.26 -0.29 -5.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.